Both IBB and XBI are ETFs. It is gross of any fee waivers or expense reimbursements. 06 as the 52 week high point — that compares with a last trade of $102. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. 01 per share, with $174. 39. 18. Shares of XBI stock opened at $73. 27. 66%. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Performance and Risk The ETF has lost about -29. Neena Mishra May 10, 2023. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. View and export this data back to 2006. 19%. XBI has traded between $73. The gross expense ratio is the fund’s total annual operating expenses ratio. The company’s fifty day. 10% of. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 1% and 1. We have highlighted five ETFs from different. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. total market composite index. Both LABU and XBI are ETFs. Share your ideas and get valuable insights from the community of like minded traders and investorsAlaunos Therapeutics, Inc. 51. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. 32% Category Average 45. 2% weight, and there are 133 holdings in total in the fund (Figure 1). Free ratings, analyses, holdings, benchmarks, quotes, and news. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. There is no guarantee the fund will achieve its stated investment objective. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. 12 and $91. 94 as the 52 week high point — that compares with a last trade of $116. The famed investor's Berkshire Hathaway (. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. VHT has a higher 5-year return than XBI (7. Looking at the chart above, XBI's low point in its 52 week range is $62. It can be found in the fund’s most recent prospectus. 79 as the 52 week high point — that compares with a last trade of $159. 2% Top Ten Holdings. 08 per unit, that means that analysts see 59. RGLD. In XBI, the top five holdings together represent only 9. 35%. VHT vs XBI. Growth of Hypothetical $10,000. 35%). Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Holdings. The ETF has lost about -12. The company has an 88. Looking at the chart above, XBI's low point in its 52 week range is $97. com if you have any further questions. 191), IBB is significantly more concentrated in its top ten holdings than XBI. $6. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. XBI has a beta of 0. ETFs are subject to market fluctuation and the risks of their underlying investments. TG Therapeutics Inc TGTX:US. News & World Report, XBI enjoys volume of 20. 7% vs -5. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Snapshot for the SPDR S&P BIOTECH ETF ETF (XBI), including recent quote, performance, objective, analyst opinions, and commentary. 11. 75. ARGX. 90 in this past 52. 47 and a beta of 0. 04 per unit, that means that analysts see 73. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Total healthcare and life sciences M&A was about $71. View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). 36% of total assets under management. View complete XLP exchange traded fund holdings for better informed ETF trading. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. IBB's and XBI's Top Holdings are About to Break Out. 41% so far, and is down about. The top ten holdings have a 48. iShares Biotechnology ETF ETF holdings by MarketWatch. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. $0. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. Net Expense Ratio. ETF Report Card. $6. Carnage in small and micro-cap biotech stocks took XBI from $111. 003 on 06/20/23 ; Management Fee 0. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. 2. Top 10 Holdings (14. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. The following charts reflect the allocation of WCLD's underlying. $0. 8% of its total assets under management. •. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Comparing XBI with other biotech ETFs, we note that XBI is one of the largest with around US$8 billion in assets under management and has one of the lowest expense ratios at 0. 250-590-1718. 5%, and a 2. XBI touched $73. 97 and standard deviation of 36. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. VEEV. 80 per share, with $92. 40. 50% vs. Holdings. Meanwhile, XBI equal weights its holdings. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. The ETF has lost about -30. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. BTEK11. Holdings. While this ETF allocates. 1. 38%. Below is the comparison between BBC and XBI. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. 68%. As of 09/30/2023. 5% year-to-date and 38. , respectively. XBI Holdings (Seeking Alpha) Risks. MRTX. BBC vs XBI. We have highlighted five ETFs from different. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. XBI currently has 133 holdings. 47% vs -5. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. LABU. Stock Analysis Chart Headlines Holdings Ownership Ratings. Growth of Hypothetical $10,000. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. 46% YTD Daily Total Return ETF Summary. The beaten-down prices offer a solid buying opportunity for investors. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Please call us for more information - (250). by Morningstar Manager Research. Health Care Fund Highlights: 137 Total Holdings $5. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. Both XBI and XLV are ETFs. 86% so far this year and is down about -32. 35% for XBI, but SBIO yields 2. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 27%. 15 per share, with $174. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 42 billion worth of net assets. 1. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. 47%. 71% of total assets under management. XBI has traded between $62. by Sweta Killa Published on September 18,2023. . Below is the comparison between BBC and XBI. 81 and $97. As of 09/30/2023. It is gross of any fee waivers or expense reimbursements. Discover historical prices for XBI stock on Yahoo Finance. XBI has a Diversified Portfolio. 19%. 06 as the 52 week high point — that compares with a last trade of $109. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. Figure 1 - XBI ETF top 10 holdings (ssga. The big biotech. While this ETF allocates. m. 250-391-1110. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. The XBI has been a leader beating other ETFs YTD, up about 35% until today. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. 1. Morningstar Medalist Rating. XBI has traded between. The top 10 holdings account for about 14. 60 as the 52 week high point — that compares with a last trade of $69. ("Boron One" or the. DLTR. 2 %. 58. SPDR S&P Biotech ETF is a equity fund issued by SSgA. View the latest ETF prices and news for better ETF investing. 84. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 06 and standard deviation of 38. One of the most popular entries among the best biotech ETFs to buy, the SPDR S&P Biotech ETF (NYSEARCA:XBI) benefits from strong volume metrics. XBI Description. 31 per share, with $92. XBI has lost 27. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. Top 10 Holdings. 5% year-to-date and 38. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. 15 billion assets under management. Region Percentage; North, Central and South America: 99. 91 (11/14/23) 1 Day XBI 0. 54%. Skip to main content. 79 as the 52 week high point — that compares with a last trade of $76. 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. Holdings. N/A. 08%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. So far this year, XBI has lost about -5. XBI has traded between $64. Market On Millstream The. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. ETFs are subject to market fluctuation and the risks of their underlying investments. Fund size is a good indication of how many other investors trust this fund. 79 as the 52 week high point — that compares with a last trade of $116. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. Its fund flows were negative $259. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. 46M), Matrix Capital Management Company LP ($188. 28% IONS Ionis Pharmaceuticals Inc Biotechnology. Performance and Risk. 2014. 78% of XBI's total assets under management. The main reason for this is the additional risk mitigation an ETF provides given its myriad holdings within a sector. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. The split for XBI took place on September 11, 2015. 33% from the latest price. Dividend Yield. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. Health Care Fund Highlights: 137 Total Holdings $5. Mettler-Toledo International Inc. Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron (REGN). 35%). 01 to $0. NAV as of Nov 16, 2023. , Biogen Inc. DLTR. Published. Seagen Inc Ordinary Shares. Discover historical prices for XBI stock on Yahoo Finance. Analyst Forecast. Performance and Risk. Assets Under Management. Reply Like (7) q. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. So far this year, XBI has lost about -5. Asset type. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. 22% of total assets) As of November 16, 2023. 70% so far this year and is down about -16. The company has an 88. 2. IBB vs. 45% and is down about -9. LABU has a higher expense ratio than XBI (1. In addition to holding 155 positions, its top 10 holdings make up just 14. 50 down to $98. Visitors trend 2W 10W 9M. The top 10 holdings account for about 10. Dollar Tree Inc. While IBB has many more holdings than XBI (376 vs. In addition, the recent spike in volatility has increased option prices even. Rather than analyzing the holdings of all ETFs and deciding which allocation is best it is easier to pick two that encompass large caps FBIOX or IBB and small/mid caps with equal weighting like the XBI. 38% vs. Looking at the chart above, XBI's low point in its 52 week range is $62. Free ratings, analyses, holdings, benchmarks, quotes, and news. Diversification. 2013. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI has an overall POWR Rating of D, equating to a Sell. Both BBC and XBI are ETFs. Net expense ratio. ETF. Learn everything about SPDR S&P Biotech ETF (XBI). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. As of Oct 31 2023. 13%) Gold 1,980. Major Holdings. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. 97. ETF Channel Staff - Friday, October 20, 6:48 AM. 58%: Halozyme Therapeutics Inc:XLY News. Performance and Risk. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. Stocks. 5. The weighted harmonic average of closing market price divided by. 81. $0. 66 +2. 08 per unit, that means that analysts see 59. 1% which highlights the scope of the fund and diversification away from company-specific risks. 80% of total assets under management. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. Shares Held Weight In Fund. XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. Performance. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Meanwhile, XBI equal weights its holdings. Performance. 46% YTD Daily Total ReturnETF Summary. Themes & Subsectors ETFs. Complete SPDR S&P Biotech ETF funds overview by Barron's. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 66% so far this year and in the past. 13 and $94. The 10 largest holdings have a combined 17. 06 and standard deviation of 38. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 7. SGEN. Thu, Nov 9, 1:16 PM ET, Market News Video. 09% of its total assets under management. 1005 Broad St 5 Victoria BC V8W 2A1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. View the XBI funds market news. During this past 52-week period, the fund has traded between. With XBI trading at a recent price near $131. Looking at the chart above, XBI's low point in its 52 week range is $62. Expense ratio and liquidity are average for the group. XBI is an equal-weighted ETF that follows the S&P Biotechnology Select Industry Index. 97. Also includes news, ETF details and other investing information. 00%) Most Recent Dividend 0. 81% of the total fund's. 2 %. Veeva Systems. Monday's ETF Movers: XBI, QCLN. The sale of ETFs is subject to an activity assessment fee (from $0. Themes & Subsectors ETFs. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. Again, top 10 holdings. 79 in February 2021 and has fallen over (50%) to $76. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. Across the 192 current stocks in the fund, all holdings have a weighting between 0. 5% position, and no other holding accounts for more than 1. Shares of XBI stock opened at $73. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 97% in the last one year (as of 11/07/2022). So far this year, XBI has lost about -5. 97. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. 65%. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. Boron One Announces First Closing of Financing. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 44 per share, with $92. Looking at the chart above, XBI's low point in its 52 week range is $62. 7% of assets. Its price to cash flow multiples is about 13. IBB outperformed the S&P 500 last year and did much better than XBI. 87. XBI holdings. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Price Chart. 35%. Company specialized in: Holding Companies. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. $156. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. IBB has a higher 5-year return than XBI (0. 51 on Tuesday. 12% over the last 12 months (as of 07/18/2023). Dividend ETFs. 0. XBI is lower by 45% over the past two years, while the S&P 500 ETF (SPY Quick Quote SPY - Free Report) is higher by 8. XBI has traded between $62. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 01% vs 8. $7. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. ARKK ARKG. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. XBI has traded between $62.